Flu shots have an exciting new role in the world of cancer therapy! A recent study shows that flu vaccines could be used to boost the effects of cancer immunotherapy. Continue reading Take your flu shots! Fighting cancer with flu vaccines.
A new migraine medication called ubrogepant recently passed a large scale phase 3 clinical trial. This medication may be able to help treat patients that cannot tolerate or do not respond to the most common types of migraine medication. Continue reading New migraine medication passes clinical trial
by Isabella Grabski figures by Jovana Andrejevic Clinical trials are critical to study the safety and effectiveness of new drugs, but they are no small endeavor. The cost of a clinical trial can range anywhere from $7 million to over $50 million, and they can take up to a decade to fully complete. Not only can this represent a substantial strain on a pharmaceutical company, it also … Continue reading Virtual Clinical Trials: Testing new drugs from afar
Doctors at Boston Children’s Hospital engineered a unique medicine to treat a young girl’s disease: they reverse engineered a blocker from her DNA to inhibit the gene causing the disease. Continue reading Individual Genetic Medicine Helps Treat Genetic Disease
Researchers have developed a minimally-invasive and precise brain drug delivery system that is controlled by an external magnetic field. Read Anqi Zhang’s article to learn more about neuron modulation by drug delivery! Continue reading Magnetic field-controlled drug delivery to the brain
Type II diabetes is a rising global epidemic without any current treatments. But scientists have designed an interesting chimeric protein that aims to increase insulin sensitivity in patients and thereby provide a potential cure. Continue reading Using Chimeric Proteins to Fight Type II Diabetes
Scientists are using carbon nanotubes to help damaged heart tissue, scarred from heart attacks, to function healthily again. Continue reading Carbon Nanotubes Restore Electrical Signals to Damaged Hearts
A group of scientists uncovered a commensal gut bacteria, Akkermansia muciniphila, that can significantly ameliorate ALS symptoms in mice, and also prolong their lifespan. Their results highlight the potential of modulating the gut microbiome to treat ALS. Continue reading The Next Ice Bucket Challenge: Modulating Your Gut Microbiome to Treat ALS
Researchers from MIT have developed a novel method to locally deliver drugs and prevent immune activity around implanted biomedical devices over several months. The method is based on the formation of crystals of immunosuppressive drugs, which can be included in devices and slowly dissolve over the course of months. While this method substantially increases the length of time tested devices can function, difficulty of crystallizing certain drugs or introducing them into specific devices may prove to be a challenge in adapting this method to other systems. Even so, for many cases, this method will likely substantially reduce the difficulty of maintaining device stability for extended periods of time. Continue reading Slow and Steady Drug Delivery Keeps Biomedical Devices Kicking
Bacteria in the human gut can modify the ingested drugs rendering them useless. Scientists discovered how the gut bacteria degrade a Parkinson’s disease medicine and found a way to stop them from stealing our drugs. Continue reading Hey, those bacteria are stealing our drugs!